389
Views
1
CrossRef citations to date
0
Altmetric
Review

Biology of Cancer; From Cellular Cancerogenesis to Supracellular Evolution of Malignant Phenotype

ORCID Icon
Pages 309-317 | Received 12 May 2017, Accepted 14 May 2018, Published online: 16 Jul 2018

References

  • Yu BD, Mukhopadhyay A, Wong C. Skin and hair: models for exploring organ regeneration. Hum Mol Genet. 2008;17:54–59.
  • Xu H, Yu S, Liu Q, Yuan X, Mani S, Pestell RG, Wu K. Recent advances of highly selective CDK4/6 inhibitors in breast cancer. J Hematol Oncol. 2017;10(1):97.
  • Brücher BL, Jamall IS. Somatic mutation theory – why it's wrong for most cancers. Cell Physiol Biochem. 2016;38:1663–1680.
  • Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet. 2003;33:245–254.
  • Allegra A, Alonci A, Penna G, et al. The cancer stem cell hypothesis: a guide to potential molecular targets. Cancer Invest. 2014;32:470–495.
  • Smythies J. Intercellular signaling in cancer-the SMT and TOFT hypotheses, exosomes, telocytes and metastases: is the messenger in the message? J Cancer. 2015;6:604–609.
  • Massi D, Landriscina M, Piscazzi A, et al. S100A13 is a new angiogenic marker in human melanoma. Mod Pathol. 2010;23:804–813.
  • Vartanian A, Karshieva S, Dombrovsky V, Belyavsky A. Melanoma educates mesenchymal stromal cells towards vasculogenic mimicry. Oncol Lett. 2016;11:4264–4268.
  • Cassidy JW. Nanotechnology in the regeneration of complex tissues. Bone Tissue Regen Insights. 2014;5:25–35.
  • Nguyen N, Couts KL, Luo Y, Fujita M. Understanding melanoma stem cells. Melanoma Manag. 2015;2:179–188.
  • Ma Y, Zhang P, Wang F, Yang J, Yang Z, Qin H. The relationship between early embryo development and tumourigenesis. J Cell Mol Med. 2010;14:2697–2701.
  • Monk M, Holding C. Human embryonic genes re-expressed in cancer cells. Oncogene. 2001;20:8085–8091.
  • Cooper DN, Ball EV, Mort M. Chromosomal distribution of disease genes in the human genome. Genet Test Mol Biomarkers. 2010;14:441–446.
  • Postovit LM, Margaryan NV, Seftor EA, et al. Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells. Proc Natl Acad Sci USA. 2008;105:4329–4334.
  • Merrell AJ, Stanger BZ. Adult cell plasticity in vivo: de-differentiation and transdifferentiation are back in style. Nat Rev Mol Cell Biol. 2016;17:413–425.
  • Vicente-Dueñas C, Gutiérrez de Diego J, Rodríguez FD, Jiménez R, Cobaleda C. The role of cellular plasticity in cancer development. Curr Med Chem. 2009;16:3676–3685.
  • Reid BJ, Levine DS, Longton G, Blount PL, Rabinovitch PS. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. Am J Gastroenterol. 2000;95:1669–1676.
  • Nantajit D, Lin D, Li JJ. The network of epithelial–mesenchymal transition: potential new targets for tumor resistance. J Cancer Res Clin Oncol. 2015;141:1697–1713.
  • Stevens LC. The development of transplantable teratocarcinomas from intratesticular grafts of pre- and postimplantation mouse embryos. Dev Biol. 1970;21:364–382.
  • Tanaka S, Nakanishi MO, Shiota K. DNA methylation and its role in the trophoblast cell lineage. Int J Dev Biol. 2014;58:231–238.
  • Rahmat K, Vijayananthan A, Abdullah B, Amin S. Benign teratoma of the liver: a rare cause of cholangitis. Biomed Imaging Interv J. 2006;2:e20.
  • Harms D, Zahn S, Göbel U, Schneider DT. Pathology and molecular biology of teratomas in childhood and adolescence. Klin Padiatr. 2006;218:296–302.
  • Zaharescu I, Moldovan AD, Tanase C. Natural killer (NK) cells and their involvement in different types of cancer. Current status of clinical research. J Mind Med Sci. 2017;4:31–37.
  • Ratner N, Brodeur GM, Dale RC, Schor NF. The “neuro” of neuroblastoma: neuroblastoma as a neurodevelopmental disorder. Ann Neurol. 2016;80:13–23.
  • Brodeur GM, Bagatell R. Mechanisms of neuroblastoma regression. Nat Rev Clin Oncol. 2014;11:704–713.
  • Evans AE, Gerson J, Schnaufer L. Spontaneous regression of neuroblastoma. Natl Cancer Inst Monogr. 1976;44:49–54.
  • Wang JX, Fukunaga-Kalabis M, Herlyn M. Crosstalk in skin: melanocytes, keratinocytes, stem cells, and melanoma. J Cell Commun Signal. 2016;10:191–196.
  • Kinsler V, Shaw AC, Merks JH, Hennekam RC. The face in congenital melanocytic nevus syndrome. Am J Med Genet A. 2012;158:1014–1019.
  • Papac RJ. Spontaneous regression of cancer: possible mechanisms. In Vivo. 1998;12:571–578.
  • Chakraborty C, Gleeson LM, McKinnon T, Lala PK. Regulation of human trophoblast migration and invasiveness. Can J Physiol Pharmacol. 2002;80:116–124.
  • Shih IM, Kurman RJ. Expression of melanoma cell adhesion molecule in intermediate trophoblast. Lab Invest. 1996;75:377–388.
  • Ugurel S, Reinhold U, Tilgen W. HLA-G in melanoma: a new strategy to escape from immunosurveillance? Onkologie. 2002;25:129–134.
  • Ali S, Mulryan K, Taher T, Stern PL. Immunotherapy success in prophylaxis cannot predict therapy: prime-boost vaccination against the 5T4 oncofoetal antigen. Cancer Immunol Immunother. 2007;56:165–180.
  • Curigliano G, Criscitiello C, Gelao L, Goldhirsch A. Molecular pathways: human leukocyte antigen G (HLA-G). Clin Cancer Res. 2013;19:5564–5571.
  • White RM, Zon LI. Melanocytes in development, regeneration, and cancer. Cell Stem Cell. 2008;3:242–252.
  • Bailey CM, Morrison JA, Kulesa PM. Melanoma revives an embryonic migration program to promote plasticity and invasion. Pigment Cell Melanoma Res. 2012;25:573–583.
  • Dvořánková B, Szabo P, Kodet O, et al. Intercellular crosstalk in human malignant melanoma. Protoplasma. 2016;254(3):1143–1150.
  • Díez-Torre A, Andrade R, Eguizábal C, et al. Reprogramming of melanoma cells by embryonic microenvironments. Int J Dev Biol. 2009;53:1563–1568.
  • Astigiano S, Damonte P, Fossati S, Boni L, Barbieri O. Fate of embryonal carcinoma cells injected into postimplantation mouse embryos. Differentiation. 2005;73:484–490.
  • Li L, Connelly MC, Wetmore C, Curran T, Morgan JI. Mouse embryos cloned from brain tumors. Cancer Res. 2003;63:2733–2736.
  • Sell S, Nicolini A, Ferrari P, Biava PM. Cancer: a problem of developmental biology; scientific evidence for reprogramming and differentiation therapy. Curr Drug Targets. 2016;17:1103–1110.
  • Haldi M, Ton C, Seng WL, McGrath P. Human melanoma cells transplanted into zebrafish proliferate, migrate, produce melanin, form masses and stimulate angiogenesis in zebrafish. Angiogenesis. 2006;9:139–151.
  • Kaufman CK, Mosimann C, Fan ZP, et al. A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation. Science. 2016;351:2197.
  • Hendrix MJ, Seftor EA, Seftor RE, Kasemeier-Kulesa J, Kulesa PM, Postovit LM. Reprogramming metastatic tumour cells with embryonic microenvironments. Nat Rev Cancer. 2007;7:246–255.
  • Kasemeier-Kulesa JC, Teddy JM, Postovit LM, et al. Reprogramming multipotent tumor cells with the embryonic neural crest microenvironment. Dev Dyn. 2008;237:2657–2666.
  • Brankov N, Prodanovic EM, Hurley MY. Pigmented basal cell carcinoma: increased melanin or increased melanocytes? J Cutan Pathol. 2016;43:1139–1142.
  • Wang J, Pantopoulos K. Regulation of cellular iron metabolism. Biochem J. 2011;434:365–381.
  • Neve A, Corrado A, Cantatore FP. Osteocalcin: skeletal and extra-skeletal effects. J Cell Physiol. 2013;228:1149–1153.
  • Cole JB, Manyama M, Larson JR, et al. Human facial shape and size heritability and genetic correlations. Genetics. 2017;205:967–978.
  • Devor EJ. Transmission of human craniofacial dimensions. J Craniofac Genet Dev Biol. 1987;7:95–106.
  • Gerozissis K. Brain insulin, energy and glucose homeostasis; genes, environment and metabolic pathologies. Eur J Pharmacol. 2008;585:38–49.
  • Franklin C, Livingstone E, Roesch A, Schilling B, Schadendorf D. Immunotherapy in melanoma: recent advances and future directions. Eur J Surg Oncol. 2017;43:604–611.
  • Koller KM, Mackley HB, Liu J, et al. Improved survival and complete response rates in patients with advanced melanoma treated with concurrent ipilimumab and radiotherapy versus ipilimumab alone. Cancer Biol Ther. 2017;18:36–42.
  • Hermel DJ, Ott P. Combining forces: the promise and peril of synergistic immune checkpoint blockade and targeted therapy in metastatic melanoma. Cancer Metastasis Rev. 2017;36(1):43–50.
  • Stern PL, Brazzatti J, Sawan S, McGinn OJ. Understanding and exploiting 5T4 oncofoetal glycoprotein expression. Semin Cancer Biol. 2014;29:13–20.
  • Stern PL, Harrop R. 5T4 oncofoetal antigen: an attractive target for immune intervention in cancer. Cancer Immunol Immunother. 2016;66:415–426.
  • Myers KA, Rahi-Saund V, Davison MD, Young JA, Cheater AJ, Stern PL. Isolation of a cDNA encoding 5T4 oncofetal trophoblast glycoprotein. An antigen associated with metastasis contains leucine-rich repeats. J Biol Chem. 1994;269:9319–9324.
  • Amato RJ, Stepankiw M. Clinical efficacy of TroVax in the treatment of progressive castration-resistant prostate cancer. Clin Med Insights Oncol. 2012;6:67–73.
  • Harrop R, Treasure P, de Belin J, et al. Analysis of pre-treatment markers predictive of treatment benefit for the therapeutic cancer vaccine MVA-5T4 (TroVax). Cancer Immunol Immunother. 2012;61:2283–2294.
  • Motofei IG. Herpetic viruses and spontaneous recovery in melanoma. Med Hypotheses. 1996;47:85–8.
  • Day D, Hansen AR. Immune-related dverse events associated with immune checkpoint inhibitors. BioDrugs. 1996;30:571–584.
  • Arenberger P, Fialova A, Gkalpakiotis S, Pavlikova A, Puzanov I, Arenbergerova M. Melanoma antigens are biomarkers for ipilimumab response. J Eur Acad Dermatol Venereol. 2017;31:252–259.
  • Bekyarova G, Atanasova M, Tzaneva M, Dimitrova A. Melatonin modulates inflammatory response and suppresses burn-induced apoptotic injury. J Mind Med Sci. 2017;4:59–66.
  • Wang Y, Mo Y, Gong Z, et al. Circular RNAs in human cancer. Mol Cancer. 2017;16:25.
  • Li P, Chen H, Chen S, et al. Circular RNA 0000096 affects cell growth and migration in gastric cancer. Br J Cancer. 2017;116:626–633.
  • Qin B, Shu Y, Xiao L, et al. MicroRNA-150 targets ELK1 and modulates the apoptosis induced by ox-LDL in endothelial cells. Mol Cell Biochem. 2017;429(1–2):45–58.
  • Kumar L, Shamsuzzama, Haque R, Baghel T, Nazir A. Circular RNAs: the emerging class of non-coding RNAs and their potential role in human neurodegenerative diseases. Mol Neurobiol. 2017; 54(9):7224–7234.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.